Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding Agent
Authors:
- 1 February 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 106 (2) , 283-288
Abstract
Background: Sugammadex rapidly reverses rocuronium-induced neuromuscular block. This study explored the dose-response relation of sugammadex given as a reversal agent at reappearance of the second muscle twitch after rocuronium- and vecuronium-induced block. A secondary objective was to investigate the safety of single doses of sugammadex. Methods: In this two-center, phase II, dose-finding study, 80 patients (age >or= 18 yr, American Society of Anesthesiologists physical status I or II, surgery >or= 60 min requiring muscle relaxation for intubation) were randomly assigned to receive rocuronium (0.60 mg/kg) or vecuronium (0.10 mg/kg). Sugammadex or placebo was administered at reappearance of the second muscle twitch. The primary efficacy endpoint was time from starting sugammadex administration until recovery of the train-of-four ratio to 0.9. Results: Compared with placebo, sugammadex produced dose-dependent decreases in mean time to recovery for all train-of-four ratios in the rocuronium and vecuronium groups. The mean time for recovery of the train-of-four ratio to 0.9 in the rocuronium group was 31.8 min after placebo compared with 3.7 and 1.1 min after 0.5 and 4.0 mg/kg sugammadex, respectively. The mean time for recovery of the train-of-four ratio to 0.9 in the vecuronium group was 48.8 min after placebo, compared with 2.5 and 1.4 min after 1.0 and 8.0 mg/kg sugammadex, respectively. Sugammadex was well tolerated. Conclusion: Sugammadex rapidly reversed rocuronium- or vecuronium-induced neuromuscular block at reappearance of the second muscle twitch and was well tolerated. A dose-response relation was observed with sugammadex for reversal of both rocuronium- and vecuronium-induced neuromuscular block.Keywords
This publication has 16 references indexed in Scilit:
- Postoperative Residual Paralysis in Outpatients Versus InpatientsAnesthesia & Analgesia, 2006
- Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeysBritish Journal of Anaesthesia, 2005
- Reversal of high-dose rocuronium with Org 25969European Journal of Anaesthesiology, 2005
- Clinical tests are worthless in predicting objective neuromuscular recoveryEuropean Journal of Anaesthesiology, 2005
- Impact of Anesthesia Management Characteristics on Severe Morbidity and MortalityAnesthesiology, 2005
- Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is usedActa Anaesthesiologica Scandinavica, 2002
- A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin‐Based Synthetic HostAngewandte Chemie International Edition, 2002
- Residual neuromuscular block is a risk factor for postoperative pulmonary complications A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuroniumActa Anaesthesiologica Scandinavica, 1997
- Comparative use of muscle relaxants and their reversal in three European countries: a survey in France, Germany and Great BritainEuropean Journal of Anaesthesiology, 1996
- Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuroniumActa Anaesthesiologica Scandinavica, 1995